Michele Ann McTigue

Person

Encinitas, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Azalactam compounds as HPK1 inhibitors
- Patent number 11,684,616
- Issue date Jun 27, 2023
- Pfizer Inc.
- Joyann Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azalactam compounds as HPK1 inhibitors
- Patent number 11,142,525
- Issue date Oct 12, 2021
- Pfizer Inc.
- Rebecca Anne Gallego
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted carbonucleoside derivatives useful as anticancer agents
- Patent number 10,709,709
- Issue date Jul 14, 2020
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted nucleoside derivatives useful as anticancer agents
- Patent number 10,428,104
- Issue date Oct 1, 2019
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted carbonucleoside derivatives useful as anticancer agents
- Patent number 10,220,037
- Issue date Mar 5, 2019
- Pfizer Inc.
- John Howard Tatlock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic derivatives for the treatment of diseases
- Patent number 9,133,215
- Issue date Sep 15, 2015
- Pfizer Inc.
- Simon Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic derivatives for the treatment of diseases
- Patent number 8,680,111
- Issue date Mar 25, 2014
- Pfizer Inc.
- Simon Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modifications of the VEGF receptor-2 protein and methods of use
- Patent number 6,849,721
- Issue date Feb 1, 2005
- Agouron Pharmaceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modifications of the VEGF receptor-2 protein and methods of use
- Patent number 6,794,146
- Issue date Sep 21, 2004
- Agouron Pharmaceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modifications of the VEGF Receptor-2 Protein and methods of use
- Patent number 6,784,285
- Issue date Aug 31, 2004
- Agouron Pharmaceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modifications of the VEGF receptor-2 protein and methods of use
- Patent number 6,753,416
- Issue date Jun 22, 2004
- Agouron Pharmaceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modifications of the VEGF receptor-2 protein and methods of use
- Patent number 6,316,603
- Issue date Nov 13, 2001
- Agouron Pharmaceuticals, Inc.
- Michele A. McTigue
- C30 - CRYSTAL GROWTH

Patents Applicationslast 30 patents

Information Patent Application
Azalactam Compounds as HPK1 Inhibitors
- Publication number 20240197703
- Publication date Jun 20, 2024
- Pfizer Inc.
- Joyann Barber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azalactam Compounds as HPK1 Inhibitors
- Publication number 20220401424
- Publication date Dec 22, 2022
- Pfizer Inc.
- Joyann Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Azalactam Compounds as HPK1 Inhibitors
- Publication number 20200172539
- Publication date Jun 4, 2020
- Pfizer Inc.
- Rebecca Anne Gallego
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20190111060
- Publication date Apr 18, 2019
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20170348313
- Publication date Dec 7, 2017
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20160244475
- Publication date Aug 25, 2016
- Pfizer Inc.
- John Howard Tatlock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES
- Publication number 20140135339
- Publication date May 15, 2014
- Pfizer Inc.
- Simon BAILEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES
- Publication number 20130252961
- Publication date Sep 26, 2013
- Pfizer Inc.
- Simon BAILEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystal structure of VEGFRKD: ligand complexes and methods of use t...
- Publication number 20050197492
- Publication date Sep 8, 2005
- Agouron Pharmaceuticals, Inc.
- Steven Lee Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Catalytic domains of the human hepatocyte growth factor receptor ty...
- Publication number 20040009568
- Publication date Jan 15, 2004
- Barbara Mroczkowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modifications of the VEGF receptor-2 protein and methods of use
- Publication number 20020164641
- Publication date Nov 7, 2002
- Agouron Pharamceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modifications of the VEGF receptor-2 protein and methods of use
- Publication number 20020127538
- Publication date Sep 12, 2002
- Agouron Pharamceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modifications of the VEGF receptor-2 protein and methods of use
- Publication number 20020051965
- Publication date May 2, 2002
- Agouron Pharamceuticals, Inc.
- Michele A. McTigue
- C07 - ORGANIC CHEMISTRY

Michele Ann McTigue

Person

Patents Grantslast 30 patents

Azalactam compounds as HPK1 inhibitors

Azalactam compounds as HPK1 inhibitors

Substituted carbonucleoside derivatives useful as anticancer agents

Substituted nucleoside derivatives useful as anticancer agents

Substituted carbonucleoside derivatives useful as anticancer agents

Macrocyclic derivatives for the treatment of diseases

Macrocyclic derivatives for the treatment of diseases

Modifications of the VEGF receptor-2 protein and methods of use

Modifications of the VEGF receptor-2 protein and methods of use

Modifications of the VEGF Receptor-2 Protein and methods of use

Modifications of the VEGF receptor-2 protein and methods of use

Modifications of the VEGF receptor-2 protein and methods of use

Patents Applicationslast 30 patents

Azalactam Compounds as HPK1 Inhibitors

Azalactam Compounds as HPK1 Inhibitors

Azalactam Compounds as HPK1 Inhibitors

SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES

MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES

Crystal structure of VEGFRKD: ligand complexes and methods of use t...

Catalytic domains of the human hepatocyte growth factor receptor ty...

Modifications of the VEGF receptor-2 protein and methods of use

Modifications of the VEGF receptor-2 protein and methods of use

Modifications of the VEGF receptor-2 protein and methods of use